Cellectar Biosciences, Inc. (CLRB)
Market Closed
12 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
2. 23
-0.02
-0.8889%
Pre Market
$
+0.29 +13.0045% 2. 52
7.53M Market Cap
- P/E Ratio
- Div Yield
69,480 Volume
-3.91 Eps
$ 2.25
Previous Close Investors:
Want to track CLRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cellectar Biosciences, Inc. (CLRB) Statistics
Valuation metrics
Market Cap 7.53M
Enterprise value 299.98K
Trailing P/E (ttm) -0.45
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 2
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 66K
Average volume (90 days) 1.24M
Price summary
52-Week low 2.2
52-Week high 12
Beta -
50-Day moving average 2.95
200-Day moving average 3.13
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 24 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.87%
Return on equity -2.65%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.97
Total debt (mrq) -
Total Debt/Equity (mrq) 0.32
Current ratio (mrq) 1.9%
Book value per share (mrq) 1.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
